Partners will use electrons from Oranjewind offshore wind farm to produce 45,000 tonnes per year of renewable H2 across two ...
Militaries and startups use artificial intelligence to sift through vast amounts of data and power autonomous underwater ...
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...
Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...
30 patients with Wiskott-Aldrich syndrome have been treated with etuvetidigene autotemcel. Credit: Telethon Foundation via LinkedIn. Italian research charity Telethon Foundation is one step closer to ...
Amgen's dividend yield remains attractive, with a moderate payout ratio and strong free cash flow. Click here to see why AMGN ...
Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...
Amgen said one of its early-stage obesity programs has been put on a clinical hold by the FDA, while reiterating its ambitions to become a … ...
Biotech company Amgen (NASDAQ:AMGN ... we are investing heavily in our rapidly advancing pipeline to deliver innovative therapies across our four therapeutic areas," said Robert A.
Management emphasized its commitment to driving pipeline development, especially in emerging therapeutic areas like oncology and rare diseases. Updates on MariTide, Amgen's weight-reduction ...
With strong performance globally, we are investing heavily in our rapidly advancing pipeline to deliver innovative ... by analysts >> Read More on AMGN: Amgen NewsMORE Related Stocks Indices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback